Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07413744 · ClinicalTrials.gov registry record · Phase 2
The Gut - PRO Study
A Phase 2 study, sponsored by University of Wisconsin, Madison.
- Not yet
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT07413744 is a Phase 2 study that has not yet begun recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 40 participants.
The verdict
NCT07413744, a Phase 2 study, has not yet begun recruiting, sponsored by University of Wisconsin, Madison.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and feasibility of an oral probiotic supplement (PS) intervention in individuals with dementia or mild-cognitive impairment (MCI) due to Alzheimer's disease or at risk of dementia due to Alzheimer's disease (AD). 40 participants will be enrolled and can expect to be on study for up to 1 year.
Interventions
- OTHER Placebo
- DRUG Probiotic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-08 |
| Est. Completion | 2029-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07413744
The ClinicalTrials.gov registry entry for NCT07413744 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07413744 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07413744 about?
NCT07413744 is a clinical study titled "The Gut - PRO Study". The purpose of this study is to assess the safety and feasibility of an oral probiotic supplement (PS) intervention in individuals with dementia or mild-cognitive impairment (MCI) due to Alzheimer's disease or at risk of dementia due to Alzheimer's disease (AD). 40 participants will be enrolled and ...
What is the current status of trial NCT07413744?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2026-08. Estimated completion is 2029-03.
What interventions are being tested in trial NCT07413744?
The interventions under investigation include: Placebo (OTHER), Probiotic (DRUG).
Who is sponsoring clinical trial NCT07413744?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.